AANA Journal Course: Current State of Pain Treatment: Does Dexmedetomidine Have a Role to Play?

Add to Cart

Members

Non-Members

Class A Credits: 1

Format: PDF

Course Launch Date: 3/9/21

Course Expires: 3/9/24

Member/Associate: $0.00

Non-Member: $0.00

Opioids are a mainstay in the modern practice of anesthesia and perioperative pain management. However, due to the crisis surrounding opioid use and abuse, as well as the undesirable side effects that occur with normal use, anesthesia providers are searching for ways to curtail perioperative opioid use. The advent of various analgesic adjuncts such as dexmedetomidine has opened new avenues for multimodal analgesic approaches to perioperative pain management.

The American Association of Nurse Anesthetists is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center's Commission on Accreditation.

AANA is an approved provider by the California Board of Registered Nursing, CEP #10862.


Post-Test Attempt Notice
A minimum passing score of 80% is required to pass this course. You have TWO opportunities to achieve a passing score. If you fail to achieve a passing score of 80%, you will not receive CE credit for this course.

Content Disclaimer:

The views, information, or opinions expressed within the videos and audio are solely those of the individuals involved and do not necessarily represent those of the American Association of Nurse Anesthetists.

Course content has been prepared by the presenter/developer, and each viewer agrees that the presenter/developer is solely responsible for the content and the accuracy thereof. The viewer agrees that the American Association of Nurse Anesthetists has no responsibility or liability for the accuracy or completeness of the content.

  • Discuss the current climate of opioid use and why opioid sparing techniques are being utilized.
  • Define pain and discuss its physiology.
  • Discuss the pharmacology of opioids and the advantages and disadvantages of their use.
  • Discuss the mechanism of action of dexmedetomidine and its physiologic effects.
  • List patient populations where dexmedetomidine may be of benefit.

Ryan Wiatrowski, DNAP, CRNA


rocket-idle